Population coverage by HLA class-I restricted cytotoxic T-lymphocyte epitopes

Area of Science:

• Immunology
• Vaccinology
• Computational Biology

Background:

• Cytotoxic T-lymphocyte (CTL) epitopes are a key component of modern vaccines.
• Their specificity to human leukocyte antigen (HLA) alleles limits broad population coverage.
• HLA supertypes offer potential for wider immunization but epitope derivation methods vary.

Purpose of the Study:

• To assess the feasibility of achieving 90% multi-ethnic population coverage with CTL epitopes.
• To determine the number of unique CTL epitopes required under different specificity assumptions.
• To evaluate coverage using human cytomegalovirus (CMV) derived epitopes.

Main Methods:

• Utilized two large datasets to estimate peptide requirements for 90% group-specific coverage.
• Assessed coverage based on specificity to single serologic or molecular HLA types.
• Evaluated a clinically relevant epitope repertoire from human CMV proteins.

Main Results:

• Attainable 90% coverage for some ethnic groups with 11 HLA-restricted CTL epitopes.
• Additional 4+ CTL epitopes needed for 90% coverage in Black or Asian populations.
• 90% multi-ethnic coverage feasible without cross-reactivity, but may need 2-3x more epitopes than initially estimated.

Conclusions:

• CTL epitope-based vaccines can achieve high coverage in diverse populations.
• Careful selection of numerous, specific CTL epitopes is crucial for broad ethnic group inclusion.
• Current HLA supertype or serologic grouping methods may underestimate epitope requirements for multi-ethnic vaccine strategies.